Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;26(11):920-930.
doi: 10.1111/nep.13957. Epub 2021 Aug 9.

Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease

Sayanthooran Saravanabavan  1   2 , Gopala K Rangan  1   2
Affiliations
Review

Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease

Sayanthooran Saravanabavan et al. Nephrology (Carlton). 2021 Nov.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic renal disease in adults and is due to heterozygous germ line variants in either PKD1, PKD2 or rarely other genes. It is characterized by marked intra-familial disease variability suggesting that other genetic and/or environmental factors are involved in determining the lifetime course ADPKD. Recently, research indicates that polycystin-mediated mitochondrial dysfunction and metabolic re-programming contributes to the progression of ADPKD. Although biochemical abnormalities have gained the most interest, variants in the mitochondrial genome could be one of the mechanisms underlying the phenotypic variability in ADPKD. This narrative review aims to evaluate the role of the mitochondrial genome in the pathogenesis of APDKD.

Keywords: autosomal dominant polycystic kidney disease; metabolic reprogramming; mitochondrial genome.

PubMed Disclaimer

References

REFERENCES

    1. Heyer CM, Sundsbak JL, Abebe KZ, et al. Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(9):2872-2884.
    1. Rangan GK, Alexander SI, Campbell KL, et al. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease. Nephrology (Carlton). 2016;21(8):705-716.
    1. Halvorson CR, Bremmer MS, Jacobs SC. Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment. Int J Nephrol Renov Dis. 2010;3:69-83.
    1. Luciano RL, Dahl NK. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant. 2013;29(2):247-254.
    1. Lanktree MB, Guiard E, Li W, et al. Intrafamilial variability of ADPKD. Kidney Int Rep. 2019;4(7):995-1003.

Substances

LinkOut - more resources